HLA-C and neoplasm: Approaches like epigenetic modulation or inhibition of lysosomal degradation are particularly suited for tumours with reversible MHC downregulation, as they reactivate endogenous antigen presentation and sensitize tumours to T cell‐mediated killing.152, 153